Ferring’s inflammatory bowel disease drug approved
The Korea Food and Drug Administration on Friday authorized Ferring’s sustained release drug “Pentasa (mesalazine).”
Mesalazine is an...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
